← Companies|Cartesian Therapeutics
RN

Cartesian Therapeutics

RNAC·NASDAQGaithersburg MDFounded 201480 employees
Micro CapbiotechPublicImmunology
Platform: mRNA Cell
Market Cap
$0.2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (RNAC)
Loading RNAC stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TixacageneRNA-5678Preclinical1mAbSMN2DLL3 ADCMDSMS
TezesotorasibRNA-470Preclinical1Cell TherapySHP2EGFRiLNCRC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)
2031-01-11
Tezesotorasib Interim
LN
Interim
2031-12-14
Tixacagene Interim
MDS
Interim